Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (11-20 of 320) with videos related to

Pageof 32
Sort By:
The Lancet. Oncology|February 13, 2016
Rare cancers: a sea of opportunityNiki Boyd, Janet E Dancey, C Blake Gilks, et al.
The Journal of Pathology|January 19, 2018
Clear cell carcinomas of the ovary and kidney: clarity through genomicsJennifer X Ji, Yi Kan Wang, Dawn R Cochrane, et al.
Gynecologic Oncology Reports|June 15, 2026
Granulosa cell tumors and menopausal hormone therapy: A narrative reviewAbigail Shore, Lanlan Fang, Shelley Hewins, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
Gynecologic Oncology|February 1, 2011
Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010Michael S Anglesio, Mark S Carey, Martin Köbel, et al.
Cancers|November 28, 2013
Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studiesCécile Le Page, David G Huntsman, Diane M Provencher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2021
Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation statusJulia R Naso, Basile Tessier-Cloutier, Janine Senz, et al.
Gynecologic Oncology|January 1, 2008
The prognostic significance of elongation factor eEF1A2 in ovarian cancerDixie E Pinke, Steve E Kalloger, Tanja Francetic, et al.
The Surgical Clinics of North America|August 2, 2008
Hereditary diffuse gastric cancer: prophylactic surgical oncology implicationsHenry T Lynch, Edibaldo Silva, Debrah Wirtzfeld, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
Pageof 32

Showing results (11-20 of 320) with videos related to

Sort By:
Pageof 32
The Lancet. Oncology|February 13, 2016
Rare cancers: a sea of opportunityNiki Boyd, Janet E Dancey, C Blake Gilks, et al.
The Journal of Pathology|January 19, 2018
Clear cell carcinomas of the ovary and kidney: clarity through genomicsJennifer X Ji, Yi Kan Wang, Dawn R Cochrane, et al.
Gynecologic Oncology Reports|June 15, 2026
Granulosa cell tumors and menopausal hormone therapy: A narrative reviewAbigail Shore, Lanlan Fang, Shelley Hewins, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
Gynecologic Oncology|February 1, 2011
Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010Michael S Anglesio, Mark S Carey, Martin Köbel, et al.
Cancers|November 28, 2013
Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studiesCécile Le Page, David G Huntsman, Diane M Provencher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2021
Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation statusJulia R Naso, Basile Tessier-Cloutier, Janine Senz, et al.
Gynecologic Oncology|January 1, 2008
The prognostic significance of elongation factor eEF1A2 in ovarian cancerDixie E Pinke, Steve E Kalloger, Tanja Francetic, et al.
The Surgical Clinics of North America|August 2, 2008
Hereditary diffuse gastric cancer: prophylactic surgical oncology implicationsHenry T Lynch, Edibaldo Silva, Debrah Wirtzfeld, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
Pageof 32